Understand the Place in Therapy of Delafloxacin
May 2026
Delafloxacin (Baxdela) is a new oral and IV quinolone antibiotic.
It will be a twice-daily option for treating bacterial skin infections or community-acquired bacterial pneumonia (CABP) in adults.
Delafloxacin seems to have better coverage than other quinolones for gram-positive bacteria...including MRSA...and it also covers many gram-negative bacteria, anaerobes, and atypical bacteria.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive